TRIM21-mediated ubiquitination of PARP1 regulated by the PI3K/AKT-STAT5A axis suppresses small cell lung cancer

作者
Guozhen Cao,Gongfeng Li,Xiaolin Wang,Tengfei Zhang,Xinhuang Yao,Peng Hou,Jiahui Zhang,Xiaopeng Guo,Jiarong Wang,Li Xiang,Hongbin Ji,Chenchen Guo,Wenchu Lin
出处
期刊:Nature Communications [Nature Portfolio]
卷期号:17 (1) 被引量:2
标识
DOI:10.1038/s41467-026-73271-1
摘要

Abstract Abnormal accumulation of Poly(ADP-ribose) polymerase 1 (PARP1) is implicated in the progression of several cancers. However, the mechanisms responsible for PARP1 protein stabilization remain incompletely understood. In this study, we identify E3 ubiquitin ligase tripartite motif-containing 21 (TRIM21) as a novel PARP1-binding partner. PARP1 directly interacts with TRIM21 via its HD domain, while the PRY-SPRY domain of TRIM21 is essential for this interaction. Consequently, TRIM21 facilitates the polyubiquitination of PARP1 at the K654 residue, promoting its degradation under physiological conditions. Functionally, we show that TRIM21 is significantly downregulated in small cell lung cancer (SCLC), and its tumor-suppressive potential appears partly mediated by its interaction with PARP1 and the subsequent degradation of PARP1, which supports DNA damage repair and maintains genomic integrity. Additionally, we reveal that the PI3K/AKT pathway suppresses TRIM21 expression through transcription factor STAT5A, which impedes the ubiquitination and degradation of PARP1. Notably, combining the PI3K/AKT inhibitor PKI-587 with the PARP inhibitor (PARPi) BMN673 yields enhanced anti-tumor effects in both in vitro and in vivo models of SCLC. Collectively, our findings establish the “PI3K/AKT-STAT5A-TRIM21-PARP1” signaling axis as a critical pathway in SCLC tumorigenesis. Dual inhibition of this axis with PI3K/AKT inhibitors and PARPi offers promising therapeutic potential for SCLC treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
希望天下0贩的0的应助被Co采纳,获得30
刚刚
xixi发布了新的文献求助10
刚刚
1秒前
FashionBoy的应助被伶俐的不评采纳,获得10
1秒前
Orange的应助被留无影采纳,获得30
1秒前
烦人糕糕完成签到,获得积分10
1秒前
无花果的应助被伶俐的不评采纳,获得10
1秒前
秋风的应助被伶俐的不评采纳,获得10
1秒前
共享精神的应助被AA采纳,获得10
2秒前
2秒前
2秒前
orixero的应助被伶俐的不评采纳,获得10
2秒前
Nole的应助被伶俐的不评采纳,获得10
2秒前
充电宝的应助被伶俐的不评采纳,获得10
2秒前
wanci的应助被伶俐的不评采纳,获得10
2秒前
斯文败类的应助被伶俐的不评采纳,获得10
3秒前
刘亚梅完成签到 ,获得积分10
4秒前
Jasper的应助被简单的浩然采纳,获得30
5秒前
倩倩完成签到,获得积分10
6秒前
可科研和发布了新的文献求助10
6秒前
7秒前
Tao2023发布了新的文献求助30
7秒前
7秒前
蓦然回首完成签到,获得积分10
8秒前
8秒前
打打的应助被DW采纳,获得10
10秒前
10秒前
12秒前
我是谁的应助被wang采纳,获得100
12秒前
14秒前
Nole的应助被欣慰的嘉熙采纳,获得10
14秒前
wan完成签到,获得积分10
15秒前
15秒前
留无影发布了新的文献求助30
16秒前
16秒前
ooo发布了新的文献求助10
17秒前
johnkkk111完成签到,获得积分10
17秒前
zxf完成签到,获得积分20
18秒前
勤劳锦程完成签到 ,获得积分10
18秒前
科研通AI6.3的应助被罐装采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188295
求助须知:如何正确求助?哪些是违规求助? 9576112
关于积分的说明 21845392
捐赠科研通 7786320
什么是DOI,文献DOI怎么找? 3435276
关于科研通互助平台的介绍 2559581
邀请新用户注册赠送积分活动 2482182